Madrid promises pharma sector regulatory stability & increased investment
This article was originally published in Scrip
Executive Summary
The Spanish government has assured the pharmaceutical industry that there will be regulatory stability following recent austerity measures, including obligatory medicine price discounts which have hit the industry hard, Farmaindustria, the R&D-based pharmaceutical industry association, told Scrip.